Today, the FDA granted a label expansion approval for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody, a companion diagnostic, to identify patients with HR-positive ...
The best carpet stain removers can be a lifesaver. Many of us have been there, and witnessed that moment when time slows down and a glass of red wine tumbles and splashes across your light carpet.
And, as it turns out, Tide Free & Gentle is great for pretreating stains too, especially greasy or oily ones. I took this advice, but to make pretreating easier, I put Tide in a spray bottle with ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Knowing our proclivity for enthusiastic eating I’ve naturally become a stain-removal connoisseur over the years. Every pen, stick, sheet, gel and spray has found its way into my rotation at one point ...
Daniela is a freelance writer who covers lifestyle and culture. In her free time, she's either cuddling with her goldendoodle Chai, buying plants, or having a picnic. Daniela is a Chicana from Los ...
The FDA has specified use of the Ventana Pathway anti-HER2/neu (4B5) antibody assay. Additionally, the American Society for Clinical Pathology has guidelines for testing for HER2. Support for the ...
Treatment for HER2-positive breast cancer depends on tumor size and spread but may involve a combination of chemotherapy, targeted therapy, monoclonal antibody therapy, and kinase inhibitors.
Enhertu is approved for HR-positive, HER2-low or -ultralow metastatic breast cancer after endocrine therapy progression, based on DESTINY-Breast06 trial results. Enhertu showed a 36% reduction in ...
In the HER2-low population, treatment with trastuzumab deruxtecan reduced the risk of disease progression or death by 38% compared with chemotherapy. The Food and Drug Administration (FDA ...